Rivaroxaban for thromboprophylaxis after hospitalization for medical illness

Spyropoulos, Alex C.; Ageno, Walter; Albers, Gregory W.; Elliott, C. Gregory; Halperin, Jonathan L.; Hiatt, William R.; Maynard, Gregory A.; Steg, P. Gabriel; Weitz, Jeffrey I.; Suh, Eunyoung; Spiro, Theodore E.; Barnathan, Elliot S.; Raskob, Gary E.; Jur

View/Open

a3549.pdf (369.1Kb)

Author

Spyropoulos, Alex C.

Ageno, Walter

Albers, Gregory W.

Elliott, C. Gregory

Halperin, Jonathan L.

Hiatt, William R.

Maynard, Gregory A.

Steg, P. Gabriel

Weitz, Jeffrey I.

Suh, Eunyoung

Spiro, Theodore E.

Barnathan, Elliot S.

Raskob, Gary E.

Jur

Metadata

Show full item record

URI

https://hdl.handle.net/20.500.12032/110563

Description

BACKGROUND Patients who are hospitalized for medical illness remain at risk for venous thromboembolism after discharge, but the role of extended thromboprophylaxis in the treatment of such patients is a subject of controversy. METHODS In this randomize

Collections

Documentos - PUJB

Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc/4.0/